KRAS rs61764370 in epithelial ovarian cancer-letter

Clinical Cancer Research

Volumn 17, Issue 20, 2011, Pages 6600-

  Weidhaas, Joanne B ^a   Slack, Frank J ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RISK; DISEASE MARKER; FAMILY HISTORY; GENE; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; KRAS GENE; LETTER; MEDICAL HISTORY; ONCOGENE; OVARY CANCER; PATIENT SELECTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS;

EID: 80054119241     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-1195     Document Type: Letter

References (5)

1. Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implicationsfor clinical testing. ClinCancerRes2011;17:3742-50.
2. Ratner E, Lu L, Boeke M, Barnett R, Nallur S, Chin L, et al. A KRASvariant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res 2010;15:6509-15.
3. Paranjape T, Heneghan H, Lindner R, Keane F, Hoffman A, Hollestelle A, et al. A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis. Lancet Oncol 2011;12:377-86.
4. Christensen BC,Moyer BJ, Avissar M,Ouellet LG, Plaza SL,McClean MD, et al. A let-7 binding site polymorphism in the KRAS 3′UTR is associated with reduced survival in oral cancers. Carcinogenesis 2009;30:1003-7.
5. Chin L, Ratner E, Leng S, Zhai R, Nullur S, Babar I, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk. Cancer Res 2008;68:8535-40.